Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2025-12-24 @ 11:08 PM
NCT ID:
NCT00002069
Eligibility Criteria:
Inclusion Criteria
Concurrent Medication:
Allowed:
* Zidovudine (AZT).
Exclusion Criteria
Co-existing Condition:
Patients with the following are excluded:
* Active opportunistic infection or progressive Kaposi's sarcoma (KS).
* Dementia.
* Lymphoma.
Concurrent Medication:
Excluded within 3 weeks of study entry:
* Other experimental AIDS therapy.
Patients with the following are excluded:
* Active opportunistic infection or progressive Kaposi's sarcoma (KS).
Patients must be either HIV seropositive or have AIDS or AIDS related complex (ARC) and have life expectancy of at least 6 months.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00002069
Study Brief:
Protocol Section:
NCT00002069